当前位置：
X-MOL 学术
›
Cardiovasc. Res.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
REPRIEVE and CANTOS trials: lessons learned towards eliminating cardiovascular disease in human immunodeficiency virus by combined targeting of LDL and inflammation.
Cardiovascular Research ( IF 10.2 ) Pub Date : 2024-09-09 , DOI: 10.1093/cvr/cvae152 Annet Kirabo 1, 2, 3, 4, 5
中文翻译：
REPRIEVE 和 CANTOS 试验：通过联合靶向 LDL 和炎症来消除人类免疫缺陷病毒心血管疾病的经验教训。
更新日期：2024-09-09
Cardiovascular Research ( IF 10.2 ) Pub Date : 2024-09-09 , DOI: 10.1093/cvr/cvae152 Annet Kirabo 1, 2, 3, 4, 5
Affiliation
中文翻译：
REPRIEVE 和 CANTOS 试验：通过联合靶向 LDL 和炎症来消除人类免疫缺陷病毒心血管疾病的经验教训。
京公网安备 11010802027423号